Triple
T36599537
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | fam-trastuzumab deruxtecan |
E902880
|
entity |
| Predicate | isContraindicatedIn |
P23156
|
FINISHED |
| Object | patients with known serious hypersensitivity to trastuzumab deruxtecan components |
—
|
LITERAL FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: patients with known serious hypersensitivity to trastuzumab deruxtecan components | Statement: [fam-trastuzumab deruxtecan, isContraindicatedIn, patients with known serious hypersensitivity to trastuzumab deruxtecan components]
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f76e66b7b88190848f7a3e1188915f |
completed | May 3, 2026, 3:48 p.m. |
| NER | Named-entity recognition | batch_69f7c30bc2448190b0daa9a288dec5b2 |
completed | May 3, 2026, 9:50 p.m. |
Created at: May 3, 2026, 4:11 p.m.